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a b s t r a c t
A link has been suggested between Autism Spectrum Disorder (ASD) and anxiety disorders. The aim of
the study was to examine the severity of social anxiety measured by the Liebowitz Social Anxiety Scale
Self-Report and prevalence of Social Anxiety Disorder (SAD) in adults with ASD, with SAD and a non-ASD
comparison group. Individuals with ASD showed signiﬁcantly higher scores of social anxiety and social
avoidance relative to the comparison group, but signiﬁcantly lower scores relative to the SAD sample.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Individuals with autism spectrum disorder (ASD) show high
rates of psychiatric comorbidity (for a review see Mazzone et al.,
2012). Children and adolescents with ASD appear to be especially
prone to develop social anxiety (Bellini, 2004; Kuusikko et al.,
2008). Contributing factors to social anxiety could be sensory
oversensitivity, difﬁculties in perspective taking and limited capa-
city in socializing with others (American Psychiatric Association,
2013). Most children with ASD have also experienced repeated
rejection (Cappadocia et al., 2012; Bejerot and Humble, 2013),
which may result in social anxiety and avoidance.
Social withdrawal and being quiet in social situations characterize
social anxiety disorder (SAD) and these behaviors are also commonly
observed in ASD (Eriksson et al., 2013). These may initially confuse
the picture of ASD, resulting in too frequent SAD diagnoses and
delays in establishing ASD. For example, Rydén and Bejerot (2008)
found that 17% of an adult psychiatric outpatient sample had been
diagnosed with SAD prior to establishing ASD. However, a recent
study (Lugnegård et al., 2011) has suggested an occurrence of SAD in
22%, of a previously identiﬁed adult ASD sample.
Hitherto, studies have focused on social anxiety in children and
adolescents with ASD, whereas the occurrence of SAD among adults
has been sparsely studied. In this study, we similar to Lugnegård
et al. (2011) examined the occurrence of SAD in an adult ASD sample.
In addition, we examined the severity of social anxiety and avoidance
in comparison to adults with SAD and a non-ASD comparison group.
2. Methods
2.1. Participants
Fifty adults with ASD, 53 subjects in a non-ASD comparison group and 100
individuals with SAD participated in the study. Participants with ASD and the non-
ASD comparison group were derived from a study by Bejerot et al. (2012), and
participants with SAD from a randomized treatment study by Mörtberg et al.
(2007).
Participants with a diagnosis of ASD were recruited through an outpatient
tertiary psychiatric unit for diagnosing ASD, a community-based facility for adult
ASD, and in six cases, through a Swedish ASD web-site. Prior to the current study, a
tertiary outpatient psychiatric team specialised in diagnosing ASD, and located in
Stockholm, Sweden had carefully examined these participants. The team included a
senior psychiatrist and an experienced psychologist in addition to other staff
members. The assessments took at least 18 h to complete over a period of 2–3
weeks. A parental interview supporting ASD in the offspring was a requirement for a
diagnosis of autism, Asperger disorder or atypical autism.
Participants were included if they were between 20 and 47 years. Exclusion
criteria were any neurological or genetic syndrome, psychosis, any disease or
medication affecting androgen status, any congenital syndrome, diagnosed malforma-
tions, intellectual disability or having attended education for children with intellectual
disability in primary or secondary school. Twenty-seven participants were taking
psychotropic medication (antidepressants (N¼20), anxiolytics (N¼5), hypnotics
(N¼5), stimulants (N¼3), antipsychotics (N¼3), mood-stabilizers (N¼2) and anti-
histamine (N¼2).
Participants in the non-ASD comparison group was a convenience sample
recruited in order to match the ASD sample in age and gender. The Mini International
Neuropsychiatric Interview (M.I.N.I.) (Allgulander et al., 2006; Lecrubier et al., 1997)
was used to assess psychiatric disorders. One subject fulﬁlled the diagnostic criteria for
SAD. Other current psychiatric disorders were major depression (n¼1), panic disorder
(n¼2), alcohol dependency (n¼6) and antisocial personality disorder (n¼1). One
subject was medicated with psychotropic medication, due to recurrent depressions.
The inclusion and exclusion criteria were identical to those reported above.
Additional exclusion criteria were self-reported ASD and ASD in a ﬁrst-degree
family member. One individual was using an antidepressant.
Participants with SADwere recruited through advertisements in local newspapers.
Inclusion criteria of the original trial were a primary diagnosis of social phobia
according to DSM-IV and age between 18 and 65 years, no current psychiatric disorder
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(i.e. depressive episode, bipolar disorder, acute stress disorder, addiction, or psy-
choses), no current psychotropic medication or psychotherapy and absence of autistic
traits (assessed by the High-Functioning Autism/Asperger Syndrome Global Scale,
Bejerot et al., 2001).
2.2. Procedures
The ASD diagnosis was established by clinical interview, supported by the
Autism Diagnostic Observation Schedule (Lord et al., 2000), and review of previous
patient records and rating scales. Co-existing psychiatric disorders were assessed
with the M.I.N.I. (Allgulander et al., 2006; Lecrubier et al., 1997).
The SAD diagnosis was established by diagnostic interview using the Structured
Clinical Interview for DSM-IV (SCID) (First et al., 2002). A satisfactory interrater
reliability (κ¼0.76) for the interviewers' SAD diagnoses has previously been reported
(Mörtberg et al., 2007).
2.3. Measures
Liebowitz Social Anxiety Scale Self-Report (LSAS-SR) is a scale for evaluating a wide
range of social situations that are described as difﬁcult for individuals with social
anxiety. The scale contains 24 items, 13 concerning performance anxiety and 11
concerning social interaction anxiety. Each item is rated separately for fear (0–3¼none,
mild, moderate, severe) and avoidance behavior (0–3¼never, occasionally, often,
usually). The LSAS-SR has demonstrated good psychometric properties as indicated by
the results of test-retest reliability, internal consistency (with Cronbach's α varying from
0.83 to 0.95 (Mattick and Clarke, 1998; Fresco et al., 2001)) and convergent and
discriminant validity and compares well to the clinician-administered version
(Liebowitz, 1985; Fresco et al., 2001; Baker et al., 2002). The average LSAS-SR score of
a healthy population is 13.5 (S.D.: 12.7) and in SAD 73.4 (S.D.: 23.2) (Fresco et al., 2001).
High-Functioning Autism/Asperger Syndrome Global Scale (HAGS) is a clinician-
rated measure of autistic traits in adults of normal intelligence (Bejerot et al., 2001).
Autistic traits are determined by assessing appearance, behavior and functional
impairment. Observations of social and emotional reciprocity, social competence,
interest, rigidity, values, self-reﬂection, speech and language, body posture, gestures,
facial expression and eye-to-eye contact are integrated into a four-level Likert scale
(1¼an exceptionally empathic and socially competent personality, 2¼more or less
normal, ‘like most people’, 3¼an emotional bluntness and pathological personality with
autistic traits, clearly noticeable during the interview, 4¼an extremely odd personality,
the person gives a peculiar and clearly autistic impression early in the interview).
Ratings of 1 and 2 are signs of normal functioning, and 3 and 4 of autistic traits. The
HAGS has satisfactory interrater reliability (κ¼0.67).
The Autism Spectrum Quotient (AQ) is a 50 item self-evaluation questionnaire,
assessing personal preferences and habits (Baron-Cohen et al., 2001). Subjects rate
to what extent they agree or disagree with the statements on a 4-point Likert scale,
with answer categories “deﬁnitely agree”; “slightly agree”; “slightly disagree” and
“deﬁnitely disagree”. AQ has satisfactory internal consistency with Cronbach's α
varying from 0.63 to 0.78 (Baron-Cohen et al., 2001; Kurita et al., 2005).
3. Results
The gender distribution did not differ between groups. One-way
Analysis of Variance (ANOVA) showed a signiﬁcant difference in LSAS-
SR scores between ASD, SAD and subjects in the non-ASD comparison
group (LSAS-SR Anxiety: F (2, 202)¼104.1 Po0.001; LSAS-SR Avoid-
ance: F (2, 202)¼96.9 Po0.001). Posthoc Bonferroni analyses showed
higher scores of anxiety and avoidance in SAD relative to both ASD
and subjects in the non-ASD comparison group (Po0.001), and
higher scores of anxiety and avoidance in ASD relative to subjects
in the non-ASD comparison group (Po0.001) Table 1.
Twenty-eight percent (14 of 50) of individuals with ASD fulﬁlled
the diagnostic criteria for SAD according to the M.I.N.I. Their mean
LSAS-SR score was 77. 9 (S.D.: 24.6), indicating that severity of social
anxiety in this subgroup of ASD was similar to the clinical SAD group.
Within the ASD group, the 14 individuals that fulﬁlled the criteria for
social anxiety had a higher AQ score, 34.6 (S.D.: 7.5), than the rest of
the group 28.1 (S.D.: 8.7), t (d.f.)¼2.4(48), P¼0.02.
Moreover, AQ scores were strongly correlated with LSAS-SR scores
among the ASD participants (LSAS-SR Anxiety: r¼0.67, Po0.001 and
LSAS-SR Avoidance: r¼0.56, Po0.001) as well as in the subjects in the
non-ASD comparison group (LSAS-SR Anxiety: r¼0.55, Po0.001 and
LSAS-SR Avoidance r¼0.50, Po0.001). No relationship was found
between age and LSAS-SR scores in any of the groups.
4. Discussion
In this study we have shown high rates of social anxiety among
adults with ASD and normal intelligence. Although the overall
ratings of social anxiety and social avoidance were lower than
those reported by people with SAD, they were substantially higher
than those of the non-ASD comparison group. The occurrence of
SAD within this ASD sample was only slightly higher than the 22%
reported by Lugnegård et al. (2011) based on the SCID interview.
Nevertheless, there may be differences in the quality of social
anxiety in ASD and SAD. According to Eriksson et al. (2013), two items
in the social anxiety domain of the RAADS-14 Screen (the 14 item
screen version of the Ritvo Autism and Asperger Diagnostic Scale-
Revised) were found to successfully discriminate ASD from SAD. These
two items “It is very difﬁcult for me to work and function in groups” and
“How to make friends and socialize is a mystery to me”, were scored
higher by individuals with ASD than by individuals with SAD,
suggesting different experiences in the groups. These items are closely
related to the social interaction difﬁculties of people with ASD, and
may not reﬂect anxiety at all.
An important difference between SAD and ASD is the presence of
social awkwardness. Individuals with SAD sense that they are socially
incompetent, although they have appropriate social skills, whereas
the ASD group is socially awkward, regardless whether they have
insight into their poor social skills or not. Hence, individuals with
ASD and poor insight may be protected from developing social
anxiety, however insight was not explicitly measured in our study.
Nevertheless, general endorsement of ASD symptoms should reﬂect
insight in an ASD population. In this study greater endorsement of
autistic symptoms measured with the AQ, was associated with more
severe social anxiety measured with the LSAS-SR. In a study on
adolescents with ASD low levels of empathy and low social anxiety
were associated, and as empathy scores increased so did social
anxiety, up to a certain level (Bellini, 2004). The author proposed
that either unawareness of, or perhaps being unconcerned with how
people perceive them, could be protective factors for social anxiety. A
recent study on social cognition and anxiety in children did however
Table 1
Demographic characteristics and social anxiety symptoms in subjects with ASD, with SAD and in the non-ASD comparison group.
ASD (n: 50) SAD (n: 100) Non-ASD comparison group (n: 53)
Age, mean (S.D.), range 30.0 (7.3), 27.9–32.1 34.6 (9.1) 32.8–36.4 32.3 (10.8), 28.4–32.5
Higher educationa (n/%) 24 (48) 43 (43) 45 (85)
Cohabitant, (n/%) 9 (18) 49 (49) 26 (49)
Males/females, % 52/48 37/63 52.8/47.2
LSAS-SR Anxiety, mean (S.D.) 30.7(15.9) 40.7 (12.0) 10.7 (7.9)
LSAS –SR Avoidance, mean (S.D.) 25.9 (13.5) 35.7 (11.5) 9.2 (7.8)
Note: LSAS-SR¼Liebowitz Social Anxiety Scale, self-report.
a University/University College.
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fail to show a relationship, but social anxiety was not speciﬁcally
targeted in that study (Hollocks et al., 2014).
A clinical observation, though not measured by the LSAS-SR, is
the high prevalence of physiological signs in SAD (such as blush-
ing, sweating and tremor) (Bögels et al., 2010), which are rarely
observed in ASD. In addition, small talk in a one-to-one setting
with a person with SAD generally proceeds smoothly, in contrast
to small talk with a person with ASD.
In comparison with healthy controls, behavioral avoidance and
social anxiety is shown to increase by age among children and
adolescents with ASD, whereas behavioral avoidance is shown to
decrease by age among controls (Kuusikko et al., 2008). The
present study indicates that social avoidance and social anxiety
will continue into adulthood, and age will not inﬂuence the level
of social anxiety in adult ASD. Individuals with ASD are likely to
suffer from social anxiety, which to a large extent may contribute
to the social avoidance typically seen in this population.
Limitations of the present study are the small sample sizes, and
assessments at different time points. However, as ASD and SAD are
chronic disorders, different time points should not affect the
results. The strengths of this study are the careful diagnostic
procedures with structured interviews and rating scales with
sound psychometric properties.
Future studies should focus on similarities and discrepancies in
the quality of social anxiety and avoidance in ASD and SAD, and
further determine the causes of social avoidance in ASD.
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